feed,title,long_url,short_url
Benzinga,Nordic Nanovector completes enrolment into second safety cohort of follicular lymphoma patients in Archer-1 Phase 1b BetalutinÂ®/rituximab combination trial,https://www.benzinga.com/pressreleases/20/11/n18440702/nordic-nanovector-completes-enrolment-into-second-safety-cohort-of-follicular-lymphoma-patients-in,https://j.mp/35LU32Z
